Hi Eva,
I think the Social Science Prediction Platform (alongside a friend of mine who is doing something similar for clinical trials) are among the more interesting uses of forecasting/āPMs but Iām skeptical they will be uptaken to the degree/āimpact you might hope for.
do forecasts inform 1% of their funding or what?
Iām skeptical of things of the form āsmall percentage chance * big numberā. I think humans are really bad at estimating small percentages.
Would be happy to talk privately about any situations you are thinking of.
Yea, this is fair. I am much more sympathetic to non-PM forecasting than I am PM/ājudgemental forecasting. The ideas in this post were really developed in 2023/ā2024 when I saw EAs spending a ton of time on Manifold/āMetaculus, investing at high valuations, generally revering prediction markets for decision making, etc. whereas what I was seeing was completely different.
I really believe in following the money. I think if we spend $100M on forecasting and $90M of it went to prediction market-style forecasting, I think itās fair to basically lump it all together. Itād be one thing if PMs were a small experiment within broad forecasting, but its been the main thing.